Literature DB >> 19252789

Opsoclonus-myoclonus-ataxia syndrome and HIV seroconversion.

Ana Ayarza, Virginia Parisi, Javier Altclas, Daniela Visconti, Gabriel Persi, Carlos A Rugilo, Emilia M Gatto.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19252789     DOI： 10.1007/s00415-009-5046-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  11 in total

1.  [Opsoclonus-myoclonus in a patient with AIDS: a good response to treatment with IV immunoglobulins].

Authors:  I García-Morales; J Porta-Etessam; R Saiz-Díaz; C Gómez-Escalonilla; L Galán; G Parrilla; J A Molina
Journal:  Rev Neurol       Date:  1999 Dec 16-31       Impact factor: 0.870

Review 2.  An update on opsoclonus.

Authors:  Agnes Wong
Journal:  Curr Opin Neurol       Date:  2007-02       Impact factor: 5.710

3.  Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.

Authors:  Ioannis Markakis; Eleni Alexiou; Michael Xifaras; Georgios Gekas; Antonios Rombos
Journal:  Clin Neurol Neurosurg       Date:  2008-04-22       Impact factor: 1.876

4.  Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.

Authors:  L Bataller; F Graus; A Saiz; J J Vilchez
Journal:  Brain       Date:  2001-02       Impact factor: 13.501

Review 5.  Natural history of HIV-1 infection.

Authors:  E N Vergis; J W Mellors
Journal:  Infect Dis Clin North Am       Date:  2000-12       Impact factor: 5.982

6.  Opsoclonus-myoclonus in an HIV-infected child on antiretroviral therapy--possible immune reconstitution inflammatory syndrome.

Authors:  Ronald van Toorn; Helena Rabie; James M Warwick
Journal:  Eur J Paediatr Neurol       Date:  2005-11-02       Impact factor: 3.140

Review 7.  NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.

Authors:  Alireza Minagar; Deborah Commins; J Steven Alexander; Romy Hoque; Francesco Chiappelli; Elyse J Singer; Behrooz Nikbin; Paul Shapshak
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 8.  Movement disorders and AIDS: a review.

Authors:  Winona Tse; Maria G Cersosimo; Jean-Michel Gracies; Susan Morgello; C Warren Olanow; William Koller
Journal:  Parkinsonism Relat Disord       Date:  2004-08       Impact factor: 4.891

9.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Authors:  Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

10.  Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies.

Authors:  P M Candler; R C Dale; S Griffin; A J Church; R Wait; M D Chapman; G Keir; G Giovannoni; J H Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154
View more
  3 in total

1.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

Review 2.  HIV-associated opsoclonus-myoclonus-ataxia syndrome: early infection, immune reconstitution syndrome or secondary to other diseases? Case report and literature review.

Authors:  Bruno F Guedes; Márcio A A Vieira Filho; Clarice Listik; Rafael B Carra; Cristiane B Pereira; Emanuelle R da Silva; Hélio R Gomes; José E Vidal
Journal:  J Neurovirol       Date:  2017-12-14       Impact factor: 2.643

Review 3.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.